These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 18078436)
1. Therapeutic effects of guggul and its constituent guggulsterone: cardiovascular benefits. Deng R Cardiovasc Drug Rev; 2007; 25(4):375-90. PubMed ID: 18078436 [TBL] [Abstract][Full Text] [Related]
2. Guggulsterone is a farnesoid X receptor antagonist in coactivator association assays but acts to enhance transcription of bile salt export pump. Cui J; Huang L; Zhao A; Lew JL; Yu J; Sahoo S; Meinke PT; Royo I; Pelaez F; Wright SD J Biol Chem; 2003 Mar; 278(12):10214-20. PubMed ID: 12525500 [TBL] [Abstract][Full Text] [Related]
3. Effect of guggulsterone and cembranoids of Commiphora mukul on pancreatic phospholipase A(2): role in hypocholesterolemia. Yu BZ; Kaimal R; Bai S; El Sayed KA; Tatulian SA; Apitz RJ; Jain MK; Deng R; Berg OG J Nat Prod; 2009 Jan; 72(1):24-8. PubMed ID: 19102680 [TBL] [Abstract][Full Text] [Related]
4. Guggulsterone suppresses LPS induced inflammation of human middle ear epithelial cells (HMEEC). Song JJ; Kwon SK; Cho CG; Park SW; Chae SW Int J Pediatr Otorhinolaryngol; 2010 Dec; 74(12):1384-7. PubMed ID: 20971513 [TBL] [Abstract][Full Text] [Related]
5. The hypolipidemic agent guggulsterone regulates the expression of human bile salt export pump: dominance of transactivation over farsenoid X receptor-mediated antagonism. Deng R; Yang D; Radke A; Yang J; Yan B J Pharmacol Exp Ther; 2007 Mar; 320(3):1153-62. PubMed ID: 17135343 [TBL] [Abstract][Full Text] [Related]
7. A natural product that lowers cholesterol as an antagonist ligand for FXR. Urizar NL; Liverman AB; Dodds DT; Silva FV; Ordentlich P; Yan Y; Gonzalez FJ; Heyman RA; Mangelsdorf DJ; Moore DD Science; 2002 May; 296(5573):1703-6. PubMed ID: 11988537 [TBL] [Abstract][Full Text] [Related]
8. Guggulsterone and Its Role in Chronic Diseases. Yamada T; Sugimoto K Adv Exp Med Biol; 2016; 929():329-361. PubMed ID: 27771932 [TBL] [Abstract][Full Text] [Related]
9. Guggulsterone inhibits osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand and by tumor cells by suppressing nuclear factor-kappaB activation. Ichikawa H; Aggarwal BB Clin Cancer Res; 2006 Jan; 12(2):662-8. PubMed ID: 16428513 [TBL] [Abstract][Full Text] [Related]
10. Is antagonism of E/Z-guggulsterone at the farnesoid X receptor mediated by a noncanonical binding site? A molecular modeling study. Meyer U; Costantino G; Macchiarulo A; Pellicciari R J Med Chem; 2005 Nov; 48(22):6948-55. PubMed ID: 16250653 [TBL] [Abstract][Full Text] [Related]
12. GUGULIPID: a natural cholesterol-lowering agent. Urizar NL; Moore DD Annu Rev Nutr; 2003; 23():303-13. PubMed ID: 12626688 [TBL] [Abstract][Full Text] [Related]
13. Guggulsterone for Chemoprevention of Cancer. Shishodia S; Azu N; Rosenzweig JA; Jackson DA Curr Pharm Des; 2016; 22(3):294-306. PubMed ID: 26561056 [TBL] [Abstract][Full Text] [Related]
14. Guggulsterone antagonizes farnesoid X receptor induction of bile salt export pump but activates pregnane X receptor to inhibit cholesterol 7alpha-hydroxylase gene. Owsley E; Chiang JY Biochem Biophys Res Commun; 2003 Apr; 304(1):191-5. PubMed ID: 12705905 [TBL] [Abstract][Full Text] [Related]
15. Guggulsterone, a plant sterol, inhibits NF-kappaB activation and protects pancreatic beta cells from cytokine toxicity. Lv N; Song MY; Kim EK; Park JW; Kwon KB; Park BH Mol Cell Endocrinol; 2008 Jul; 289(1-2):49-59. PubMed ID: 18343024 [TBL] [Abstract][Full Text] [Related]
16. Hypolipidemic agent Z-guggulsterone: metabolism interplays with induction of carboxylesterase and bile salt export pump. Yang D; Yang J; Shi D; Xiao D; Chen YT; Black C; Deng R; Yan B J Lipid Res; 2012 Mar; 53(3):529-539. PubMed ID: 22246918 [TBL] [Abstract][Full Text] [Related]
17. Effects of guggulsterone isolated from Commiphora mukul in high fat diet induced diabetic rats. Sharma B; Salunke R; Srivastava S; Majumder C; Roy P Food Chem Toxicol; 2009 Oct; 47(10):2631-9. PubMed ID: 19635521 [TBL] [Abstract][Full Text] [Related]
18. The guggul for chronic diseases: ancient medicine, modern targets. Shishodia S; Harikumar KB; Dass S; Ramawat KG; Aggarwal BB Anticancer Res; 2008; 28(6A):3647-64. PubMed ID: 19189646 [TBL] [Abstract][Full Text] [Related]
19. HPTLC method for guggulsterone. I. Quantitative determination of E- and Z-guggulsterone in herbal extract and pharmaceutical dosage form. Agrawal H; Kaul N; Paradkar AR; Mahadik KR J Pharm Biomed Anal; 2004 Sep; 36(1):33-41. PubMed ID: 15351045 [TBL] [Abstract][Full Text] [Related]
20. The hypolipidemic natural product guggulsterone acts as an antagonist of the bile acid receptor. Wu J; Xia C; Meier J; Li S; Hu X; Lala DS Mol Endocrinol; 2002 Jul; 16(7):1590-7. PubMed ID: 12089353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]